Biomedical Research and Therapy Logo

Biomedical Research and Therapy

Review Open Access Logo

Cytokine induced killer cell immunotherapy in cancer treatment: from bench to bed side

Arashar Arafar 1, *

  1. Immunology Department, Medical Science Institute, Nigeria
Correspondence to: Arashar Arafar, Immunology Department, Medical Science Institute, Nigeria. Email: pvphuc@hcmuns.edu.vn.
Volume & Issue: Vol. 1 No. 02 (2014) | Page No.: 71-77 |
Published: 2014-05-29

Online metrics

Statistics from the website

  • Abstract Views: 11792
  • Galley Views: 3130

Statistics from Dimensions

Statistics from PlumX
Copyright © 2014 by the author(s).

This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Cytokine-induced killer (CIK) cells are T effector cells generated by monocytes cultured and stimulated by cytokines. CIK cells were studied for more than 20 years ago. Because they can cause lysis of tumor cells that of both autologous and allogenic origins, they were used in cancer treatment.  This review aimed to summarize advancements of CIK cell research and their recent clinical applications in cancer treatment. In general, CIK cells were widely clinically used for recent 5 years. They gave promising results in breast cancer, lung cancer, renal cancer, and hepatocellular carcinoma treatment. Looking into the future, CIK cell based immunotherapy will become an important tool in cancer treatment.

Keywords: Cytokine induced killer cells Cancer treatment Immunotherapy Cell therapy
Sorry, we can not display full-text of this article in HTML format for you right now. Please get the article in PDF format instead.

Comments